Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Published Online: 2019-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Byoung Chul Cho•Chen-Yuan Lin•Chih-Hung Hsu•Chueh-Chuan Yen•Eva Holtved•Ioannis Xynos•Keisho Chin•Ken Kato•Mamoru Kodani•Masanobu Takahashi•Morihito Okada•Myung-Ju Ahn•Shigenori Kadowaki•Sung-Bae Kim•Yasuo Hamamoto•Yuichiro Doki•Yuko Kitagawa•Yutaro Kubota
